Partnering Solutions
-
Cell And Gene Therapies
4/28/2021
Accelerate your cell or gene therapeutic to market with tailored clinical and regulatory strategies and expert insights.
-
SMART First Human Dose (FHD)
A CDMO with the right team of experts can aid drug development, regulatory compliance, and clinical trial supply, accelerating timelines to first human dose clinical trials and the path to market.
-
Solutions For Sponsors And CROs
2/22/2022
Ensure appropriate ethical oversight and timely reviews with Advarra’s complete suite of independent oversight committees.
-
Optimize Your Endpoint Adjudication On A Single Platform
2/1/2023
Medidata Adjudicate is part of the Medidata Clinical Cloud™, and offers a cloud-based, end-to-end solution, with easily configurable modules enabling quick setup to manage endpoint adjudication in clinical trials. Medidata Adjudicate supports investigator sites, sponsors, CROs, data managers, and the CEC in collecting, managing, organizing, adjudicating and submitting clinical endpoint data.
-
Biometrics
4/28/2021
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
Excellence In Medical Writing, Regulatory Operations, & Quality Control
5/31/2023
Explore the many ways inSeption Group is working to grow and improve their client’s departments and companies as a whole.
-
Advancing Your Product From Development To Commercialization
2/22/2023
Harnessing decades of global drug product development and commercialization, you can rely on PCI's integrated speed solutions to simplify the supply chain.
-
Medrio RTSM
10/5/2023
The clinical research landscape is changing. Ensure that product is on shelves when and where it’s needed, improve data quality, and protect participant safety.
-
Pandemic Response Assessment
8/9/2021
In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.
-
Supporting Your Complex Immuno-Oncology Trials
3/4/2021
IQVIA Biotech offers extensive immuno-oncology (IO) expertise that spans across multiple treatment modalities (vaccines, bispecific antibodies, adoptive cell therapies [ACT], etc.) and numerous indications across hematologic malignancies and solid tumors.